{"nct_id":"NCT02593773","title":"Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Study","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2015-12-25","start_date_type":"ACTUAL","primary_completion_date":"2017-03-21","primary_completion_date_type":"ACTUAL","completion_date":"2017-03-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}